CAS: 6960-45-8; 7-Nitro-1H-Indole-2-Carboxylic Acid

该化合物是一种有机化合物,其特点是其单极结构,这是一种由苯环引信成火花环的双环化合物.一个硝基化合物组存在于7点,一个碳本酸组存在于2点,这对其独特的化学特性有帮助.该化合物通常是黄色晶体固体,在极地溶剂中溶解,反映其功能组进行氢结合的能力.它经常用于生物化学研究,特别是用于有关酶抑制的研究,并成为各种药物合成中的潜在建筑块.硝基化合物可以参与电极替代反应,而碳本酸可进行典型的酸基反应.此外,该化合物的结构允许与生物目标进行潜在互动,从而引起对药用化学的兴趣.在处理时,应当参考安全数据,因为硝基化合物可能敏感并可能构成健康风险.

结构式图片

欧盟法规

ECHA物质C&L通报REACH预注册

上下游产品

CAS号6960-46-9 7-硝基吲哚-2-羧酸乙酯 | CAS号167027-28-3 7-nitro-1H-indo... | CAS号292853-66-8 ethyl 2-[2-(2-n... | CAS号6960-42-5 7-硝基吲哚 | CAS号5192-04-1 7-氨基吲哚

合成工艺路线路线简述

    📜Ethyl 2-Methyl-3-[2-(2-Nitrophenyl)Hydrazono]Propanoate置于sodium Hydroxide体系中,用 水 作为反应溶剂,化学反应生成 7-硝基吲哚-2-甲酸
    参考文献:Discovery Of Potent Succinate-Ubiquinone Oxidoreductase Inhibitors Via Pharmacophore-Linked Fragment Virtual Screening Approach
    标题:Discovery Of Potent Succinate-Ubiquinone Oxidoreductase Inhibitors Via Pharmacophore-Linked Fragment Virtual Screening Approach
    摘要:Succinate-Ubiquinone Oxidoreductase (Sqr) Is An Attractive Target For Fungicide Discovery. Herein,We Report The Discovery Of Novel Sqr Inhibitors Using A Pharmacophore-Linked Fragment Virtual Screening Approach,A New Drug Design Method Developed In Our Laboratory. Among Newly Designed Compounds,Compound 9S Was Identified As The Most Potent Inhibitor With A Value Of 34 Nm Against Porcine Sqr,Displaying Approximately 10-Fold Higher Potency Than That Of The Commercial Control Penthiopyrad. Further Inhibitory Kinetics Studies Revealed That Compound 9S Is A Noncompetitive Inhibitor With Respect To The Substrate Cytochrome C And Dcip. Interestingly,Compounds 8A,9H,9J,And 9K Exhibited Good In Vivo Preventive Effects Against Rhizoctonia Solani. The Results Obtained From Molecular Modeling Showed That The Orientation Of The R-2 Group Had A Significant Effect On Binding With The Protein.
    DOI:10.1021/acs.Jafc.6B00325

    海关参考信息

    专利信息


    专利号:US-7563571-B1
    优先权日:2004-07-22
    标题 :MYH gene variants and use thereof
    发明人:SCHOLL THOMAS; ELIASON KRISTILYN; JUDKINS THADDEUS S
    权利人:MYRIAD GENETICS INC
    摘要:Variants in MYH gene are disclosed which can result in abnormal synthesis of MYH proteins and alteration of MYH activities. The invention provides methods for detecting the newly discovered genetic variants. Use of MYH genetic variants as biomarkers in diagnosing cancer and detecting a predisposition to cancer are also disclosed herein.

    专利号:US-6989384-B2
    优先权日:2000-06-14
    标题:Antipicornaviral compounds and compositions, their pharmaceutical uses, and materials for their synthesis
    发明人:HUA YE; LUU HIEP THE; CHAN FORA P; JOHNSON JR THEODORE O; REICH SIEGFRIED HEINZ; SKALITZKY DONALD JAMES; YANG YI; HENDRICKSON THOMAS F; CHU SHAO SONG; EASTMAN BRIAN WALTER
    权利人:AGOURON PHARMA
    摘要:Compounds of the formula: n nwhere the formula variables are as defined in the disclosure, advantageously inhibit or block the biological activity of the picomaviral 3C protease. These compounds, as well as pharmaceutical compositions containing these compounds, are useful for treating patients or hosts infected with one or more picornaviruses, such as RVP. Intermediates and synthetic methods for preparing such compounds are also described.

    专利号:US-10398732-B2
    优先权日:2016-10-13
    标题 :Compositions and methods for treating striated muscle injury, treating striated muscle atrophy and/or for promoting striated muscle growth
    发明人:WU MIAOZONG; WANG CUIFEN; BLOUGH ERIC
    权利人:MARSHALL UNIV RESEARCH CORPORATION
    摘要:Compositions and methods for treating striated muscle injury, treating striated muscle atrophy, and/or for promoting striated muscle growth are provided and include administering zinc oxide nanoparticles to a subject in need thereof. The zinc oxide nanoparticles can be adminstered before, during, and/or after exposure to an injurious stimuli, such as radiation. Administration of the zinc oxide nanoparticles reduces activation of autophagy regulators, increases striated muscle anabolism, increases DNA repair signaling, and/or increases striated muscle protein synthesis and growth.

    专利号:US-9517244-B2
    优先权日:2011-04-22
    标 题 :Therapeutic combinations for use in neoplasia
    发明人:NARAYAN SATYA; JAISWAL ARUNA S; OSTROV DAVID A; HONG SUKWON
    权利人:NARAYAN SATYA; JAISWAL ARUNA S; OSTROV DAVID A; HONG SUKWON; UNIV FLORIDA
    摘要:The invention features compositions and methods that are useful for the treatment of neoplasia (e.g., pancreatic cancer, colon cancer, brain cancer) by increasing DNA damage, reducing nucleotide synthesis, and reducing base excision repair (BER).

    供应商参考报价(招募中)

    品牌试剂参考报价(招募中)

    📌 第三方产品分析报告

    ✅ COA系统入驻 | 共享模式

    主要参考文献


    1: Bie J, Liu S, Zhou J, Xu B, Shen Z. Design, synthesis and biological evaluation of 7-nitro-1H-indole-2-carboxylic acid derivatives as allosteric inhibitors of fructose-1,6-bisphosphatase. Bioorg Med Chem. 2014 Mar 15;22(6):1850-62. doi: 10.1016/j.bmc.2014.01.047. doi: 10.1124/jpet.109.154997.
    3: Madhusudan S, Smart F, Shrimpton P, Parsons JL, Gardiner L, Houlbrook S, Talbot DC, Hammonds T, Freemont PA, Sternberg MJ, Dianov GL, Hickson ID. Isolation of a small molecule inhibitor of DNA base excision repair. Nucleic Acids Res. 2005 Aug 19;33(15):4711-24.
    4: Choi YJ, Li H, Son MY, Wang XH, Fornsaglio JL, Sobol RW, Lee M, Vijg J, Imholz S, Dollé ME, van Steeg H, Reiling E, Hasty P. Deletion of individual Ku subunits in mice causes an NHEJ-independent phenotype potentially by altering apurinic/apyrimidinic site repair. PLoS One. 2014 Jan 23;9(1):e86358. doi: 10.1371/journal.pone.0086358.
    📝 需求与反馈
    尽可能描述清楚需求与问题信息
    ×

    通知